In the private insurance market, 57.4 million adults under 65 could be potentially eligible for GLP-1 drugs Over 2 in 5 (42%) adults under 65 with private insurance could be eligible for GLP-1 drugs, based on current Food and Drug Administration (FDA) indications
Energy stabilizes, recovery from fatigue or travel is smoother, and skin may start showing subtle signs of glow
Glutathione plays a critical role in strengthening these defenses
Research published in Plastic and Reconstructive Surgery demonstrates that topical glutathione treatment in ischemic wound models significantly reduces oxidative stress and reestablishes the matrix metalloproteinase-1/tissue inhibitor of metalloproteinase-1 (MMP-1/TIMP-1) ratio, enabling adequate extracellular matrix production and reepithelization
Overuse increases the risk of complications and long-term health issues
We also offer mobile services throughout New Jersey, New York City, Philadelphia, and Bucks County